Array Biopharma, Inc. (ARRY) Tops Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts ARRY Hot Sheet
Price: $4.06 -4.25%
Revenue Growth %: -16.4%
Financial Fact:
Interest income: 70K
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: -16.4%
Financial Fact:
Interest income: 70K
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
On Monday, Array Biopharma, Inc. (NASDAQ: ARRY) reported Q1 EPS of ($0.13), $0.02 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $15.8 million versus the consensus estimate of $16.7 million.
For earnings history and earnings-related data on Array Biopharma, Inc. (ARRY) click here.
For earnings history and earnings-related data on Array Biopharma, Inc. (ARRY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- B.Riley Assumes Anika Therapeutics (ANIK) at Buy
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
